Cedars-Sinai and UCLA scientists discover potential new COVID-19 treatment
City News Service, 3-9-22, LA Daily News
Scientists from Cedars-Sinai have reported research findings that have opened the possibility to a new therapy for COVID-19 patients, a discovery made in a biologic substance created by re-engineered human skin cells. The substance stopped SARS-CoV-2, the virus that causes COVID-19, from reproducing and protected cells when tested in human lung cells, scientists reported. The research is in the early stages. The details of the therapy and findings were published in the journal Biomaterials and Biosystems.
...The new findings for potential treatment inhibits replication but also protects or repairs tissue, an important step because COVID-19 can cause symptoms that affects patients long after being infected by the virus. Scientists say there are few treatments that exist for COVID-19, and the ones that do exist focus on preventing the virus from replicating. The therapy was developed by using skin cells called dermal fibroblasts. Investigators at UCLA collaborated in the study and research.
...Investigators are planning future studies.
Full story at https://www.dailynews.com/2022/03/09/cedars-sinai-and-ucla-scientists-discover-potential-new-covid-19-treatment/.
No comments:
Post a Comment